Gene Editing Market, Global Outlook and Forecast 2024-2030
The global Gene Editing market is projected to reach US$ 5301 million by 2030.
Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
This report contains market size and forecasts of Gene Editing in Global, including the following market information:
Global Gene Editing Market Size 2025-2030, ($ millions)
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Editing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Editing Market, by Type, 2025-2030 ($ millions)
Global Gene Editing Market Segment Percentages, by Type
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
Global Gene Editing Market, by Application, 2025-2030 ($ millions)
Global Gene Editing Market Segment Percentages, by Application
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
Global Gene Editing Market, By Region and Country, 2025-2030 ($ Millions)
Global Gene Editing Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck
Horizo??n Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
